Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rocket Pharmaceuticals Inc 9 CEDARBROOK DRIVE CRANBURY NJ 08512 USA

www.rocketpharma.com P: 609-659-8001

Description:

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,173,001
Enterprise Value, $K 2,117,101
Shares Outstanding, K 90,504
Annual Sales, $ 0 K
Annual Net Income, $ -245,600 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -59,660 K
EBIT, $ -259,660 K
EBITDA, $ -252,560 K
60-Month Beta 1.07
% of Insider Shareholders 31.10%
% of Institutional Shareholders 98.39%
Float, K 62,357
% Float 68.90%
Short Volume Ratio 0.61

Growth:

1-Year Return 34.59%
3-Year Return -46.39%
5-Year Return 27.64%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -54.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.64 on 02/26/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -2.94
EPS Growth vs. Prev Qtr 14.67%
EPS Growth vs. Prev Year 30.43%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 01/05/18

RCKT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.83%
Return-on-Assets % -45.87%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.43
Book Value/Share 5.46
Interest Coverage -129.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar